Full Length Research Paper
References
|
Ahmed OB, Alfadel OO, Asghar AH, Elhassan MM (2013). Increasing prevalence of ESBL-producing Enterobacteriaceae in Sudan community patients with UTIs. Egypt. Acad. J. Biol. Sci. 5(1):17-24. |
|
|
Bar-Oz B, Preminger A, Peleg O, Block C, Arad I (2001). Enterobacter sakazakii infection in the newborn. Acta Paediatr. 90(3):356-358. |
|
|
Birnboim HC, Doly J (1979). A rapid alkline procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523. |
|
|
Boucher HW, Talbot GH, Bradley JS (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect. Dis. 48:1-12. |
|
|
Centers for Disease Control (1977). National nosocomial infection study report: annual summary 1975. Atlanta. |
|
|
Centers for Disease Control (1984). Nosocomial infection surveillance. CDC Surveillance Summaries 33:17SS– 29SS. E. |
|
|
Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, Van VinhChau N, Tuan PQ, Page AL, other authors (2007). Antimicrobial drug resistance of Salmonella entricserover Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob. Agents Chemother. 51:4315-4323. |
|
|
Dekitsch C, Schein R, Markolpulos E, Kuen B, Graninger W, Georgopoulos A (1999). Analysis of mutations to gyrA in quinolone-resistant clinical isolates of E cloacae. J. Med. Microbiol. 48:73-77. |
|
|
Eickhoff TC, Steinhauer BW, Finland M (1966). The Klebsiella-Enterobacter-Serratia division: Biochemical and serologic characteristics and susceptibility to antibiotics. Ann. Int. Med. 65:1163-1179. |
|
|
Gay KA, Robicsek J, Strahilevitz CH, Park GA, Jacoby TJ, Barrett F, Medalla TM, Chiller, Hooper DC (2006). Plasmid mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis. 43(3):297-304. |
|
|
Ghosh S, Mahaptra NR, Banerjee PC (1997). Metal resistance in Acidocella strain and plasmid mediated transfer of this character to Acidophilliummultivorum and Escherichia coli. Appl. Environ. Microbiol. 63:4523-4527. |
|
|
Hashimoto H, Kono K, MitsuhashiS (1964). Elimination of penicillin resistance of Staphylococcus aureus by treatment with acriflavine. J. Bacteriol. 88:261-262. |
|
|
Hormaeche E, Edwards PR (1960). A proposed genus Enterobacter. Int. Bull. Bacteriol. Nomencl. Taxon. 10:71-74. |
|
|
Ish-Horowicz D, Burke JF (1981). Rapid and efficient cosmid cloning. Nucleic acids Res. 9:2989-2998. |
|
|
Kirby WM (1994). Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 99:452-455. |
|
|
Lankeshwar N, Bagde US (2004). Mechanism of Antibiotic Resistance in Pathogenic Shigelladysenteriae. Asian J. Microbiol. Biotechnol. Environ. Sci. 6(2):285-290. |
|
|
Lankeshwar N, Bagde US (2013). Mechanism of Ciprofloxacin resistance in Shigelladysenteriae. Afr. J. Biotechnol. 12(41):6021-6025 |
|
|
Lankeshwar N, Bagde US (2008). Mechanism of Drug resistance in Staphylococcus aureus. Asian J. Microbiol. Biotechnol. Environ. Sci. 10(4):829-834 |
|
|
Livermore DM, Brown DFJ (2001). Detection of Beta-lactamase mediated resistance. J. Antimicrob. Chemother. 48:59-64. |
|
|
Maki DG, Rhame FS, Mackel DC, Bennett JV (1976). Nationwide epidemic of septicemia caused by contaminated intravenous products. Am. J. Med. 60:471-485. |
|
|
Maniatis T, Frisch EF, Sambrook J (1982). Large isolation of Plasmid DNA. In: Molecular Cloning: A laboratory manual ed. Maniatis T, Frisch EF and Sambrook J. Cold Spring Harbor Laboratory Press N.Y. 0879691360(pbk). pp. 86-96. |
|
|
National Committee for Clinical Laboratory Standards (NCCLS). (1999). Document M 100-S22 Performance standards for antimicrobial susceptibility testing. 22nd informational supplement. NCCLS, Wayen. pp. 44-49. |
|
|
National Committee for Clinical Laboratory Standards (NCCLS) (2001). Document M 100-S11. Performance standards for antimicrobial susceptibility testing. 9th informational supplement. NCCLS, Wayen. p. 122. |
|
|
Nazarowec-White M, Farber J (1997). E sakazakii: a review. Int. J. Food Microbiol. 34:103-113. |
|
|
Nikaido H (2001). Preventing drug access to targets: cell surface permeability barriers and in bacteria. Semin. Cell Dev. Biol. 12:215-223. |
|
|
Nordmann P, Poirel L (2005). Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56:463-469. |
|
|
Pan-Hou HS, Nishimoto M, Imura N (1981). Possible role of membrane protein in mercury resistance of Enterobacteraerogenes. Arch. Microbiol. 130:93-95. |
|
|
Paterson DL (2006). Resistance in gram-negative bacteria: enterobacteriaceae. Am. J. Med. 119(6 Suppl 1):S20-8; discussion S62-70. |
|
|
Quinn JP, DiVincenzo CA, Foster J (1987). Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. J. Infect. Dis. 155(5):942-947. |
|
|
Rice LB, (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197:1079-1081. |
|
|
Robicsek A, Jacoby GA, Hooper DC (2006). The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640. |
|
|
Rose HD, Schreier J (1968). The effect of hospitalization and antibiotic therapy on the Gram-negative fecal flora. Am. J. Med. Sci. 255:228-236. |
|
|
Sambrook J, Fritsch EF, Mantiatis T (1989). Molecular cloning; a laboratory manual. Cold Spring Harbor Laboratory Press, NY, U.S. A. |
|
|
Sanders WE, Tenney JH, Kessler RE (1996). Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin. Infect. Dis. 23:454-461. |
|
|
Stock I, Grüger T, Wiedemann B (2001). Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int. J. Antimicrob. Agents 18(6):537-545. |
|
|
Strahilevitz J, Engelstein D, Adler A, Temper V, Moses AE, Block C, Robicsek A (2007). Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumonia and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 51:3001-3003. |
|
|
Tenover FC, MacDonald LC (2005). Vacomycine-resistant Staphylococci and enterococci: epidemiology and control. Curr. Opin. Infect. Dis. 18:300-305. |
|
|
Tomoeda M, Inuzulka M, Kubo N, Nakamura S (1968). Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate. J. Bacteriol. 95:1078-1089. |
|
|
Vien LTM, Baker S, Le TPT, Thuy CT, Nga T, Hoang NVM, Campbell JL, Yen LM, Hieu NT, VinhChau NV, Farrar J, Schultsz C (2009). High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J. Med. Microbiol. 58:1585-1592. |
|
|
Wang A, Yang Y, Lu Q, Wang Y, Chen Y, Deng L, Ding H, Deng Q, Wang L, Shen X (2008). Occurrence of qnr-positive clinical isolates in Klebsiellapneumoniae producing ESBL or AmpCtype b-lactamase from five pediatric hospitals in China. FEMS Microbiol. Lett. 283:112-116. |
|
|
Yi-Wei Tang, Gary W. Procop, Persing DH (1997). Molecular diagnostics of infectious diseases. Clin. Chem. 43(11):2021-2038. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
